Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
3
×
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alnylam pharmaceuticals
astrazeneca
biotech
boston top stories
cancer immunotherapy
covid-19
deals
europe blog main
europe top stories
gene therapy
What
bio
roundup
abbvie’s
acquisitions
ahead
alzheimer’s
announced
biofourmis
bucks
cancer
celebrate
ceo
chance
collabs
congress
corner
covid
daniel
day
days
deal
democrats
divided
elections
fallout
forward
gilead
gilead’s
help
holiday
introduce
ipo
labor
looking
losses
medicines
midterm
month
o’day
panel
Language
unset
Current search:
sanofi
×
novartis
×
" seattle blog main "
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel